Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.

Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.

Čájet eará veršuvnnaid (1)

BACKGROUND: Platelet transfusions are used in modern clinical practice to prevent and treat bleeding in thrombocytopenic patients with bone marrow failure. Although considerable advances have been made in platelet transfusion therapy in the last 30 years, some areas continue to provoke debate, espec...

Bibliográfalaš dieđut
Váldodahkkit:	Stanworth, S, Hyde, C, Heddle, N, Rebulla, P, Brunskill, S, Murphy, M
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2004

Geahča maid

Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
Dahkki: Stanworth, S, et al.
Almmustuhtton: (2004)

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
Dahkki: Estcourt, L, et al.
Almmustuhtton: (2012)

Different platelet count thresholds to guide use of prophylactic platelet transfusions for patients with hematological disorders after myelosuppressive chemotherapy or stem cell transplantation
Dahkki: Estcourt, L, et al.
Almmustuhtton: (2016)

Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation
Dahkki: Estcourt, L, et al.
Almmustuhtton: (2014)

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
Dahkki: Estcourt, L, et al.
Almmustuhtton: (2015)

Prophylactic platelet transfusions
Dahkki: Estcourt, L, et al.
Almmustuhtton: (2010)

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
Dahkki: Desborough, M, et al.
Almmustuhtton: (2016)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol).
Dahkki: Estcourt, L, et al.
Almmustuhtton: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
Dahkki: Estcourt, L, et al.
Almmustuhtton: (2014)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Review)
Dahkki: Estcourt, L, et al.
Almmustuhtton: (2015)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
Dahkki: Estcourt, L, et al.
Almmustuhtton: (2014)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
Dahkki: Crighton, GL, et al.
Almmustuhtton: (2015)

Red cell transfusion for the management of upper gastrointestinal haemorrhage.
Dahkki: Hearnshaw, S, et al.
Almmustuhtton: (2009)

Red cell transfusion for the management of upper gastrointestinal haemorrhage.
Dahkki: Hearnshaw, S, et al.
Almmustuhtton: (2009)

Prophylactic platelet transfusions.
Dahkki: Pietersz, R, et al.
Almmustuhtton: (2012)

Red cell transfusion for the management of upper gastrointestinal haemorrhage.
Dahkki: Jairath, V, et al.
Almmustuhtton: (2010)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
Dahkki: Estcourt, L, et al.
Almmustuhtton: (2014)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary)
Dahkki: Crighton, GL, et al.
Almmustuhtton: (2021)

Where are the systematic reviews in transfusion medicine? A study of the transfusion evidence base.
Dahkki: Dorée, C, et al.
Almmustuhtton: (2010)

Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions.
Dahkki: Stanworth, S, et al.
Almmustuhtton: (2010)

Prophylactic platelet transfusions in patients with blood malignancies: Cost analysis of a randomized trial
Dahkki: Campbell, H, et al.
Almmustuhtton: (2014)

Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial.
Dahkki: Campbell, H, et al.
Almmustuhtton: (2014)

Prophylactic platelet transfusions in critical care – how low can you go?
Dahkki: Shah, A, et al.
Almmustuhtton: (2023)

Alternatives to prophylactic platelet transfusions
Dahkki: Estcourt, L
Almmustuhtton: (2016)

The strengths and weaknesses of the evidence base for transfusion medicine
Dahkki: Murphy, M, et al.
Almmustuhtton: (2007)

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions.
Dahkki: Estcourt, L, et al.
Almmustuhtton: (2013)

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions
Dahkki: Estcourt, L, et al.
Almmustuhtton: (2013)

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions
Dahkki: Estcourt, L, et al.
Almmustuhtton: (2013)

How to further develop the evidence base for transfusion medicine
Dahkki: Murphy, M, et al.
Almmustuhtton: (2008)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
Dahkki: Stanworth, S, et al.
Almmustuhtton: (2014)

Prophylactic plasma transfusion for patients undergoing non-cardiac surgery
Dahkki: Huber, J, et al.
Almmustuhtton: (2017)

The clinical effects of red blood cell transfusions: an overview of the randomized controlled trials evidence base.
Dahkki: Wilkinson, K, et al.
Almmustuhtton: (2011)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: A subgroup analysis of a randomized trial (CME)
Dahkki: Stanworth, S, et al.
Almmustuhtton: (2014)

Improving the evidence base for transfusion medicine: the work of the UK systematic review initiative.
Dahkki: Brunskill, S, et al.
Almmustuhtton: (2009)

How to further develop the evidence base for transfusion medicine
Dahkki: Murphy, M, et al.
Almmustuhtton: (2008)

A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia.
Dahkki: Heddle, N, et al.
Almmustuhtton: (2006)

Platelet transfusions for patients with haematological malignancies: who needs them?
Dahkki: Estcourt, L, et al.
Almmustuhtton: (2011)

A UK national survey of prophylactic platelet transfusion thresholds in non-bleeding, critically ill adults
Dahkki: Shah, A, et al.
Almmustuhtton: (2020)

Prophylactic platelet transfusions prior to surgery for people with a low platelet count
Dahkki: Estcourt, L, et al.
Almmustuhtton: (2017)

Prophylactic platelet transfusions prior to surgery for people with a low platelet count
Dahkki: Estcourt, L, et al.
Almmustuhtton: (2018)